| Business Name: |
Doezema David MD |
| Contact Person: |
David Doezema |
| Address: |
2211 Lomas Boulevard Ne, Albuquerque, New Mexico 87106 |
| Phone Number: |
(505) 272-4264 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Chavez Colbert E MD - Albuquerque, NM 87106
Neale Devon A MD - Albuquerque, NM 87106
Hsu Michael MD - Albuquerque, NM 87106
Pearsall Donald MD - Albuquerque, NM 87106
Shafer Darren M DO - Albuquerque, NM 87106
Martin John MD - Albuquerque, NM 87106
Read-Zamilpa Amber L MD - Albuquerque, NM 87106
Mc Cormick John MD - Albuquerque, NM 87106
Sims Ethan MD - Albuquerque, NM 87106
Tran Hoan P MD - Albuquerque, NM 87106
Hatch Edwin MD - Albuquerque, NM 87106
Pediatrix Medical Group Of New Mexico - Albuquerque, NM 87106
Rohloff Walter MD - Albuquerque, NM 87106
Avritt Paul MD - Albuquerque, NM 87106
Green William F MD - Albuquerque, NM 87106
Sunde Scott MD - Albuquerque, NM 87106
Rivera Toro David MD - Albuquerque, NM 87106
Gershman Mark MD - Albuquerque, NM 87106
Deligtisch Amanda MD - Albuquerque, NM 87106
Holub Basia MD - Albuquerque, NM 87106
|
The company Doezema David MD provides B2C services in the form of Doctors from its single location in New Mexico.
1 to 4 employees work for Doezema David MD, and the business now earns $100.000 to $499.999 per annum.
Doezema David MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Doezema David MD, please call David Doezema with the phone number (505) 272-4264 or visit its single location at 2211 Lomas Boulevard Ne in Albuquerque, New Mexico 87106.
The location of the single location can also be found using the coordinates 35.08753,-106.61684.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.